2023 DEA Supply Chain Conference

May 2-4, 2023

The Westin Galleria Houston

The Drug Enforcement Administration (DEA), Diversion Control Division, hosted a Supply Chain Conference May 2-4, 2023, at the Westin Galleria Houston in Houston, Texas. This conference offered those registered with the DEA as Manufacturers, Distributors, Pharmacies, Importers or Exporters the opportunity to meet, share information and discuss concerns.

This was a three-day conference. Day 1 was for manufacturers and other registrants who need quota, and for all importers and exporters. Days 2 and 3 of the conference were geared toward regulatory compliance personnel for mid-level and senior managers.

Conference Report

Tuesday, May 2, 2023 (Day 1)
Quotas and Import/Export

International Drug Treaties and the CSA
Stacy Harper-Avilla, Section Chief, Quota and UN Reporting Section

The 303 Process
Brenda Thomas, Program Analyst, Regulatory Section

Quotas – Aggregate Production Quotas, Individual Quotas, and Quota Applications
Mark Cunningham, Drug Science Specialist, Quota and UN Reporting Section

Quotas – Year End Reporting
Gregory Kavanagh, Drug Science Specialist, Quota and UN Reporting Section

Research vs Manufacturing
Minh Dang, Drug Science Specialist, Quota and UN Reporting Section

Imports and Exports of Controlled Substances and Listed Chemicals
Jacob Prieto, Acting Section Chief, Import/Export Section

Permit Applications/Declarations Process
Thomas Fahmy, Program Analyst, Import/Export Section

Re-Exports of Controlled Substances
Mark Via, Technical Information Specialist, Import/Export Section

Wednesday, May 3, 2023 (Day 2)

Registration
Holly Farrington, Program Analyst, Registration Section

Current Regulatory Priorities
Heather Achbach, Staff Coordinator, Regulatory, Drafting and Policy Support Section

ARCOS Reporting
Sam Weisman, ARCOS Team Leader, Registration Section

Chemicals
Stephanie Kolb, Staff Coordinator, Chemical Investigations Section

Employment Waivers/Theft and Loss Reporting
Rostant Farfan, Staff Coordinator, Regulatory Section

Administrative Actions
Kerry Hamilton, Section Chief, Pharmaceutical Investigations

Thursday, May 4, 2023 (Day 3)

IT Transformation
Matthew Strait, Deputy Assistant Administrator, Diversion Regulatory

Emerging Trends
Terrance Boos, Section Chief, Drug and Chemical Evaluation Section

Tableting & Encapsulating Machines LEADS Reporting
Stevie Ikner, Staff Coordinator, Import/Export Section

Stimulants, Quotas, and Shortages – DEA and FDA
Matthew Strait, Deputy Assistant Administrator, Diversion Regulatory
Paras Patel, Manager, Global Pharmacovigilance and Risk Management
Food and Drug Administration